Orchestrating the gut microbiota–mitochondrial–immune axis in gynecological diseases: mechanisms and dual-targeting therapeutic strategies

• by Haixia Tang, Yiting Zhang, Yanting Wang, Ze Zhou, Rong Sun, Rong Chen, Lijuan Yang, Mengqiu Shao, Jiabao Liao

• July 1, 2026

A metabolic marker–based diagnostic model for precancerous and malignant endometrial lesions in insulin-resistant PCOS women with sonographically suspected endometrial polyps

• by Ying Yang, Ningning Hu, Weimin Fan, Liwen Zhang, He Fei, Jun Ye, Yang Gao, Ju Yang, Jiangnan Pei, Rujun Chen

• July 13, 2026

Is MAR Associated With Hormone‐Related Cancer Risk?

A target trial emulation found small excess risks following fertility treatment, although the observed as­sociations may largely reflect underlying infertility and increased medical surveillance.

• by Andrea Surnit

• August 12, 2026

• 4 min

Case Report: Erythema gyratum repens associated with adenomyosis and endometriosis: an immunological twist?

• by Emanuele Scala, Donatella Sordi, Arlind Kalaja, Francesca Passarelli, Lidia Francesconi, Filomena Russo

• July 10, 2026